Related Experiment Videos
Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure
V Lubrano1, A Pingitore, A Carpi
1G. Monasterio Foundation, Pisa, Italy.
Insights
Heart failure (HF) is linked to increased inflammation, with higher levels of Interleukin-6 (IL-6) and TNF alpha. Low thyroid hormone (T3) levels correlate with these inflammatory markers, suggesting a role in HF progression.
Area of Science:
- Cardiology
- Endocrinology
- Biochemistry
Background:
- Heart failure (HF) involves complex biochemical changes.
- Cytokines and thyroid hormones are implicated in the pathophysiology of HF.
Purpose of the Study:
- To investigate plasma levels of Interleukin-6 (IL-6), TNF alpha, and C-reactive protein (CRP) in stable HF patients.
- To assess the relationship between these inflammatory markers and left ventricular dysfunction severity.
- To explore the association between inflammatory markers and thyroid hormone levels in HF patients.
Main Methods:
- 166 patients with non-ischemic cardiomyopathy and HF were studied.
- 48 healthy subjects served as a control group.
- High-sensitivity assays (ELISA, Immulite System) were used to quantify hs-IL-6, hs-TNF alpha, and hs-CRP.
Main Results:
- IL-6 and TNF alpha were significantly higher in HF patients compared to controls.
- Inflammatory markers (IL-6, CRP) showed a negative association with ejection fraction (EF%).
- All inflammatory markers were inversely correlated with free triiodothyronine (FT3) levels, with progressive increases observed in patients with low T3 syndrome.
Conclusions:
- Impaired T3 production and elevated inflammation are likely pathogenic mechanisms in HF progression.
- Low FT3 serum concentration is a negative prognostic indicator in HF.
- These findings highlight the interconnectedness of inflammation and thyroid hormone status in heart failure.
Unlabelled:
Cytokines and thyroid hormones are involved in the biochemical changes associated to heart failure (HF).
Aim:
Aims of the study were to investigate: plasma circulating levels of the cytokines Interleukine-6 (IL-6) TNF alpha and C reactive protein (CRP) in patients with stable HF in relation to the severity of left ventricular dysfunction; the relationship between these inflammatory markers and thyroid hormones.
Methods:
One-hundred and sixty-six patients (121 males, age 64+/-12), with non-ischemic cardiomyopathy, were admitted to the Institute of Clinical Physiology for progressive deterioration of symptoms. Forty-eight healthy subjects (30 males, age range 26-75 years) were also enrolled as control group (Group N). High sensitivity (hs)-IL-6 and hs-TNFalpha were quantified using solid phase sandwich ELISA kits. Hs-CRP was measured by Immulite System.
Results:
In the whole population (HF and N), the association between inflammatory markers and age resulted statistically significant only for IL-6 serum concentration (p<0.001) but not for TNFalpha and CRP. IL-6 and TNFalpha were strongly higher in the HF in comparison with N (p<0.001) while CRP showed a less significant difference (p<0.05). Whole population showed a negative association between IL-6 and EF% and between CRP and EF% (respectively p<0.01, r=-0.23; p<0.05, r=0.19). Comparing normal subjects with two classes of patients, respectively with EF>35% and EF<35%, we clearly observed the progressive enhancement of the inflammatory markers. Considering normal subjects, patients without and with low T3 syndrome, IL-6 and TNFalpha increased progressively from normal to patients with fT3<2 pg/ml (p<0.01 and p<0.01) while CRP only respect to the group with low T3 syndrome (p<0.01). The inflammatory markers were all inversely correlated with FT3 levels.
Conclusion:
Because low FT3 serum concentration represents a negative prognostic index, it is likely that impairment of T3 production and enhanced inflammation represent pathogenic mechanisms linked to HF progression.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Heart Failure Drugs: Inotropic Agents
Pathophysiology of Heart Failure
Myocarditis I: Introduction